Accueil>>Signaling Pathways>> PROTAC>> E3 Ligase Ligand-Linker Conjugate>>Thalidomide-piperazine-Boc

Thalidomide-piperazine-Boc

Catalog No.GC63220

La thalidomide-pipérazine-Boc est un intermédiaire qui peut être utilisé dans la synthèse de la protéine B-cell lymphoma 6 (BCL6) PROTAC.

Products are for research use only. Not for human use. We do not sell to patients.

Thalidomide-piperazine-Boc Chemical Structure

Cas No.: 2222114-64-7

Taille Prix Stock Qté
100 mg
180,00 $US
En stock
250 mg
270,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Thalidomide-piperazine-Boc is an intermediate that can be used in the synthesis of B-cell lymphoma 6 protein (BCL6) PROTAC[1].

[1]. Michael Berlin, et al. Bifunctional molecules containing an e3 ubiquitine ligase binding moiety linked to a bcl6 targeting moiety. WO2021077010A1.

Avis

Review for Thalidomide-piperazine-Boc

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Thalidomide-piperazine-Boc

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.